STOCK TITAN

Adient plc 8-K Filings

ADNT NYSE

Every 8-K that Adient plc (ADNT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ADNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADNT filings page.

Rhea-AI Summary

Adient plc (ADNT) reported that on August 20, 2026, subsidiaries Adient US LLC and Adient Global Holdings S.à r.l., together with other group entities, entered into an amendment to their Term Loan Credit Agreement. The amendment provides an additional $500 million in Incremental Term Loans, bringing total loans outstanding under the Credit Agreement to $1.12 billion as of the amendment date.

Adient states that proceeds from the Incremental Term Loans, together with cash on hand, will be used to redeem all of the $500 million outstanding principal amount of Adient Global Holdings’ 7.000% Senior Secured Notes due 2028 and to pay related fees and expenses. The Incremental Term Loans have the same maturity and terms as the existing term loans, and the obligations remain guaranteed on a secured basis by Adient plc and certain material wholly owned restricted subsidiaries.

Rhea-AI Summary

Adient plc furnished an investor presentation used at the J.P. Morgan Auto Conference in August 2026, providing a business update and outlining priorities for fiscal 2026 and 2027. Management emphasizes delivering on commitments through program execution, customer wins, and maintaining balance sheet discipline, noting $55M in share repurchases year-to-date with leverage within a stated target range and an expected upsizing of the existing authorization.

The presentation highlights resilient execution through external volatility and describes plans for margin expansion supported by continuous improvement, automation, restructuring and commercial discipline. For the Americas segment, it notes operational execution amid temporary headwinds and states that Q3 Adjusted EBITDA increased $13M year-over-year to $125M. Detailed tables compare segment net sales, Adjusted EBITDA, Adjusted Equity Income, depreciation and capex for Q1–Q3 and year-to-date fiscal 2025 versus 2026. The materials include forward-looking statements, a description of non-GAAP measures and reconciliations, and discussion of a key performance indicator labeled "business performance."

Rhea-AI Summary

Adient plc reported third‑quarter 2026 results for the three months ended June 30, 2026. Net sales were $3,929 million, up from $3,741 million a year earlier. Earnings before interest and income taxes were $114 million versus $118 million. Net income attributable to Adient was $25 million, down from $36 million, and diluted earnings per share were $0.32 versus $0.43.

On an adjusted basis, adjusted EBIT was $142 million and adjusted EBITDA was $225 million, essentially in line with the prior year’s $226 million; the adjusted EBITDA margin was 5.7% compared with 6.0%. Adjusted net income attributable to Adient was $38 million in both periods, with adjusted diluted earnings per share of $0.48 versus $0.45.

Cash generation remained solid. Cash provided by operating activities was $205 million compared with $172 million, and free cash flow was $138 million versus $115 million. As of June 30, 2026, cash and cash equivalents were $924 million, total debt was $2,388 million, net debt was $1,464 million, and the net leverage ratio was 1.66.

Rhea-AI Summary

Adient plc reports that Executive Vice President and Chief Financial Officer Mark Oswald has notified the company on July 6, 2026 that he intends to leave his position no later than December 31, 2026. The company states that his planned departure is not due to any disagreement regarding operations, policies or practices and has begun an external search for a new Chief Financial Officer.

Rhea-AI Summary

Adient plc furnished an investor presentation outlining strong growth and expansion in its China business. The company generated approximately $6 billion in Asia sales revenue in FY2025 and operates 39 manufacturing locations and 3 global tech centers across the region, with about 26,000 employees, including 2,170 engineers.

In China, Adient reports winning roughly $1.1 billion in annual business in FY2025, with around 70% of FY2025 wins from Chinese OEMs. Sales in China grew 18% in FY2026 first half while the market declined 2%. The company highlights 130 complete seat programs, over 30 innovative products commercialized since FY2025, and more than 70 automation projects in FY2026 supported by about 400 robots and 300 AGVs. Adient also formed a new strategic joint venture in December 2025 by acquiring a 49% stake in SCI (Zhangjiakou) to deepen relationships with Chinese OEMs.

Rhea-AI Summary

Adient plc reported results for the quarter ended March 31, 2026, showing a return to profitability on higher sales. Net sales rose to $3,865 million from $3,611 million, while net income improved to $44 million from a loss of $313 million, largely reflecting lower restructuring and impairment charges.

Net income attributable to Adient was $27 million, or $0.34 diluted EPS, versus a diluted loss per share of $(3.99) a year earlier. On a non‑GAAP basis, adjusted EBITDA was $223 million (down slightly from $233 million), and adjusted diluted EPS was $0.52 versus $0.69. Free cash flow improved to $8 million from $(90) million as operating cash flow turned positive.

Rhea-AI Summary

Adient plc reported board and shareholder actions from its 2026 annual meeting and approved a one-time retention grant for a key executive. The Human Capital and Compensation Committee granted Executive Vice President, Americas James Conklin a special restricted stock unit award with a grant date fair value of $500,000, vesting in two equal annual installments and subject to continued or accelerated vesting in certain termination, death, or disability situations.

Shareholders elected eight directors for one-year terms, ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 and authorized the board, through the Audit Committee, to set auditor pay. They also approved, on an advisory basis, named executive officer compensation and renewed the board’s authority under Irish law to issue shares and to opt out of statutory preemption rights.

Rhea-AI Summary

Adient plc used an investor presentation furnished with this 8-K to highlight a solid start to fiscal 2026. For Q1 FY26, consolidated revenue was about $3.6 billion, up roughly 4% year over year, and adjusted EBITDA reached $207 million, an increase of $11 million.

Free cash flow was $15 million, with a cash balance of $855 million as of December 31, 2025, and gross and net debt of about $2.4 billion and $1.5 billion. Adient repurchased $25 million of stock, or about 1.2 million shares, and noted that strong China sales and on‑shoring opportunities, plus an improved vehicle production forecast, support higher FY26 expectations for revenue, adjusted EBITDA and free cash flow.

The company also issued its 2025 Sustainability Report, emphasizing measurable progress on environmental goals and its focus on long‑term stakeholder value.

Rhea-AI Summary

Adient plc submitted a current report to note that it has released its financial results for the first quarter ended December 31, 2025. The company issued these results in a news release dated February 4, 2026.

The news release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated by reference, but it is expressly designated as “furnished” rather than “filed” for securities law purposes. No additional financial details or business updates are included in the body of this report.

Rhea-AI Summary

Adient plc and its subsidiaries amended their existing Term Loan Credit Agreement effective January 15, 2026. The Amendment reduces the interest rate margin to 2.00% for Term SOFR loans and 1.00% for Base Rate loans under the facility. Total loans outstanding under the Credit Agreement remained at $624,000,000 as of the amendment effective date, so the change focuses on pricing rather than principal. The obligations under the Credit Agreement continue to be guaranteed on a secured basis by Adient plc and certain of its material wholly owned restricted subsidiaries.

Rhea-AI Summary

Adient plc furnished a Form 8-K announcing its fourth-quarter and fiscal year results for the period ended September 30, 2025. The company made the announcement via a news release dated November 5, 2025, which is included as Exhibit 99.1.

The information in the news release is furnished and not deemed filed under the Securities Exchange Act of 1934, and is incorporated by reference only if expressly stated in a future filing. Adient’s ordinary shares trade on the NYSE under the symbol ADNT.

Rhea-AI Summary

Adient plc amended its Amended and Restated Revolving Credit Agreement. The change extends the maturity date to a date that is five years from October 17, 2025 and sets aggregate lender commitments at $1,000,000,000. The agreement continues to be guaranteed on a secured basis by the company and certain material wholly owned restricted subsidiaries.

The facility remains administered by JPMorgan Chase Bank, N.A. as administrative and collateral agent, with Adient US LLC as lead borrower. This amendment refreshes the tenor of the revolving credit line while aligning the committed size at $1.0 billion, preserving secured guarantees across key subsidiaries.

Rhea-AI Summary

Adient plc disclosed that representatives will hold meetings with certain investors in August 2025 and furnished the investor presentation used at those meetings as Exhibit 99.1 to this Form 8-K. The company states the presentation is furnished and therefore not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated. The filing identifies Adient ordinary shares (par value $0.001) trading as ADNT on the New York Stock Exchange and lists the Inline XBRL cover page as Exhibit 104.

Rhea-AI Summary

Form 8-K (Item 2.02): On 6 Aug 2025 Adient plc (ADNT) disclosed that it has furnished, rather than filed, a news release detailing results for the fiscal third quarter ended 30 Jun 2025. The release is provided as Exhibit 99.1 and is expressly incorporated into this report only by reference. No revenue, EPS, margin or guidance figures appear in the filing itself; investors must review Exhibit 99.1 to obtain the underlying financial data. The company also supplied the customary Exhibit 104 cover-page XBRL file.